Search for a doctor

Aishwarya Ravindran, M.B.B.S.

  1. Hematopathologist
Request an Appointment

Publications

  1. Crocker M, Fortugno A, Jerew K, Burns M, Goyal G, Ravindran A, Pavlidakey P, Elston C. Multiple Adult Onset Xanthogranulomas associated with LRCH1-FLT3 Fusion with Response to Sorafenib. Abstract presented as platform at the American Society of Dermatopathology 61st Annual Meeting. 2026.
  2. Gao M, Chen Y, Bachiashvili K, Vachhani PJ, Jamy O, Harada S, Mackinnon AC, Singh N, Ravindran A, Reddy BV, Carroll AJ, Mikhail FM. Case Report: KMT2A amplification in two adult patients with B-cell acute lymphoblastic leukemia Front. Oncol.. 2026.
  3. Rallapalle V, Kumar, Shukla B, Rech KL, Go RS, Abeykoon JP, Bhambhvani P, Harada S, Sartori-Valinotti JC, Tobin WO, Nathoo N, Saha A, Bailey L, Sokolowski D, Ravindran A, Goyal G. Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challenge Br J Haematol. 2026.
  4. Lee AM, Gaddamanugu S, Eschbacher KL, Ravindran A. A 50-year-old man with a 12-year history of extensive pachymeningeal thickening Brain Pathol. 2026.
  5. Oskarsdottir AR, Ravindran A, Koster MJ, Abeykoon JP, Bennani NN, Shah MV, Goyal G, Go RS, Rech KL, Histio-care Network. Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic Infiltrates. Am J Surg Pathol. 2026 Jan 7 Epub 2026 Jan 07
    View PubMed
  6. Tawfiq RK, Spears GM, Young JR, Mahowald M, Tobin WO, Patgunarajah U, Ruan GJ, Yi D, Zanwar S, Rech KL, Koster MJ, Acosta-Medina AA, Gruber LM, Ravindran A, Shah MV, Bennani NN, Alhaj Moustafa M, Hilal T, Sartori-Valinotti JC, Vassallo R, Ryu J, Davidge-Pitts C, Dasari S, Witzig TE, Go RS, Goyal G, Abeykoon JP. Cardiovascular Degeneration in Erdheim-Chester Disease: Prevalence, Burden, and Outcomes. Blood Adv. 2025 Aug 28 [Epub ahead of print]
    View PubMed
  7. Tessier S, Abeykoon JP, Ruan G, Bennani NN, Shah MV, Rech KL, Ravindran A, Ryu JH, Vassallo R, Koster MJ, Davidge-Pitts CJ, Gruber LM, Tobin WO, Sartori-Valinotti JC, Hilal T, Jiang L, Moustafa MA, Ahmed AZ, Bach CR, Young JR, Goyal G, Go RS, Histio-Care Network. Epidemiology of Erdheim-Chester disease in the United States: a SEER-based analysis. Blood Neoplasia. 2026 Feb; 3 (1):100188 Epub 2025 Dec 15
    View PubMed
  8. Rallapalle V, Toral-Orduno J, Shukla B, Graham L, Kole L, Bhambhvani P, Harada S, Saha A, Bailey L, Sokolowski D, Ravindran A, Goyal G. Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK Inhibition Br J Dermatol. 2025.
  9. Hershkovitz-Rokah O, Abeykoon JP, Ravindran A, Goyal G. Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration. Haematologica. 2025 Nov 1; 110 (11):2603-2619 Epub 2025 Oct 20
    View PubMed
  10. Ravindran A, Jiang L, Ruan GJ, Dasari S, Abeykoon JP, Zanwar S, Young JR, Bach CR, McConathy JE, Bennani NN, Go RS, Goyal G, Rech KL. PD-L1 expression and response to immune checkpoint inhibitor therapy in malignant histiocytic neoplasms. Leuk Lymphoma. 2025 Sep 25; 1-10 Epub 2025 Sept 25
    View PubMed
  11. Banks SA, Decker P, Flanagan EP, Zekeridou A, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori JC, Bennani NN, Shah MV, Rech KL, Bach CR, Eckel-Passow JE, Tobin WO. Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic. Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms Blood Cancer J.. 2025.
  12. Rallapalle V, Kole L, Pavlidakey P, Bhambhvani P, Harada S, Ravindran A, Goyal G. Cutaneous Rosai-Dorfman disease with near-complete response to the MEK inhibitor cobimetinib JAAD Case Rep. 2025.
  13. Seth N, Abeykoon JP, Goyal G, Go RS, Tessier S, King RL, Ravindran A. Current Perspectives on Mesenchymal Dendritic Cell Neoplasms of Lymphoid Tissue: Insights into Ontogeny, Updates on Classification, and Clinicopathologic Characteristics. Cancers (Basel). 2025 Jun 19; 17 (12) Epub 2025 June 19
    View PubMed
  14. Makras P, Erickson D, Davidge-Pitts CJ, Diamond EL, Allen CE, McClain KL, Abeykoon JP, Go RS, Siwakoti K, Sotoudeh H, Ravindran A, Gruber LM, Goyal G. Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder. J Clin Endocrinol Metab. 2025 May 19; 110 (6):1756-1766
    View PubMed
  15. Acosta-Medina AA, Abeykoon JP, Zanwar S, Ruan GJ, Rech KL, Ravindran A, Bennani NN, Davidge-Pitts CJ, Koster MJ, Ryu JH, Shah MV, Tobin WO, Vassallo R, Young JR, Go RS, Goyal G, Mayo Clinic - University of Alabama at Birmingham Histiocytosis Working Group. Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. Leukemia. 2025 Apr; 39 (4):991-994 Epub 2025 Feb 11
    View PubMed
  16. Ravindran A, Goyal G, Morlote D, Mackinnon AC. Rosai-Dorfman disease disguised as BRAF V600E-positive histiocytosis - a diagnostic pitfall Blood Res. 2025.
  17. Evers CD 3rd, Ravindran A, Rosenblum F, Weber F. A Pelvic Mass in a Young Patient With Crohn's Disease ACG Case Rep J. 2025.
  18. Tessier S, Abeykoon J, Ruan G, Rech K, Ravindran A, Goyal G, Go R, Ravindran A. Incidence of Erdheim-Chester Disease in the United States Pediatric Blood & Cancer. 2024.
  19. Acosta-Medina AA, Yao Y, Abeykoon JP, Bennani NN, Rech KL, Ravindran A, Ruan G, Shah MV, Young J, Goyal G, Go RS. Long-Term Outcomes of Treatment of HistiocyticNeoplasms with Non-Targeted Therapy: Role of Cladribine and Interferon-Alpha. Pediatric Blood & Cancer Pediatric Blood & Cancer. 2024.
  20. Saha A, Fournier D, Pandya V, Shea LK, Abeykoon JP, Ravindran A, Sen M, Bailey LO, Diamond EL, Go RS, Bae S, Goyal G. Spectrum of Health Concerns Among Individuals with Langerhans Cell Histiocytosis: A Call for Action Pediatric Blood & Cancer. 2024.
  21. Sen M, Ruan G, Reynolds SB, Ali H, Yang X, Morlote D, Ravindran A, Shea L, Maron R, Elmets CA, Koster MJ, Abeykoon JP, Salama HA, Cao XX, Ahmed AZ, Go RS, Goyal G. A Multi-Center Study of Autoimmunity in Rosai Dorfman Disease. Pediatric Blood & Cancer Abstracts from the 40th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Goa, India from November 6–9, 2024. 2024.
  22. Tawfiq RK, Spears GM, Young J, Mahowald M, Zanwar S, Ruan G, Rech K, Koster MJ, Gruber L, Tan N, Ravindran A, Shah MV, Bennani NN, Moustafa MA, Vassallo R, Ryu J, Davidge-Pitts C, Dasari S, Witzig TE, Go RS, Goyal G, Abeykoon JP. Prevalence of Cardiovascular Morbidities in Patients with Erdheim Chester Disease Pediatric Blood & Cancer. 2024.
  23. Tessier S, Abeykoon J, Ruan G, Rech K, Ravindran A, Goyal G, Go R, Ravindran A. Incidence of Erdheim-Chester Disease in the United States Pediatric Blood & Cancer. 2024.
  24. Smith KER, Acosta-Medina AA, Dasari S, Ranatunga W, Rech KL, Ravindran A, Young JR, McGarrah PW, Ruan GJ, Zanwar SS, Li JJ, Sartori-Valinotti JC, Snider JN, Witzig TE, Goyal G, Go RS, Abeykoon JP. Personalized Medicine in Histiocytic Disorders: Novel Targets in Patients Without MAPK Alterations. JCO Precis Oncol. 2024 Nov; 8:e2400471 Epub 2024 Nov 22
    View PubMed
  25. Nathoo N, Uhm JH, Porter AB, Hammack J, Jaeckle KA, Mrugala MM, Crum BA, Flanagan EP, Pittock SJ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Bach C, Ravindran A, Sartori Valinotti JC, Bennani NN, Abeykoon JP, Shah MV, Hook CC, Rech KL, Go RS, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Clinical features and outcomes in primary nervous system histiocytic neoplasms. Blood Cancer J 2024 Jun 20; 14 (1):101 Epub 2024 June 20
    View PubMed
  26. Ruan GJ, Zanwar S, Ravindran A, Schram S, Abeykoon JP, Hazim A, Young JR, Shah MV, Bennani NN, Jiang L, Morlote D, Rech KL, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis. Am J Hematol. 2024 May; 99 (5):871-879 Epub 2024 Feb 26
    View PubMed
  27. Agarwal A, Ravindran A, Donahue J, Eltoum IE, Abozeed M. Extranodal Rosai-Dorfman Disease: a rare presentation involving anterior chest wall in a middle-aged female Skeletal Radiol. 2024.
  28. Goyal G, Acosta-Medina AA, Abeykoon JP, Dai C, Ravindran A, Vassallo R, Ryu JH, Shah MV, Bennani NN, Young JR, Bach CR, Ruan GJ, Zanwar S, Tobin WO, Koster MJ, Davidge-Pitts CJ, Gruber LM, Dasari S, Rech KL, Go RS. Long-term outcomes among adults with Langerhans cell histiocytosis. Blood Adv. 2023 Nov 14; 7 (21):6568-6578
    View PubMed
  29. Acosta-Medina AA, Kemps PG, Zondag TCE, Abeykoon JP, Forma-Borst J, Steenwijk EC, Feijen EAM, Teepen JC, Bennani NN, Schram SM, Shah MV, Davidge-Pitts C, Koster MJ, Ryu JH, Vassallo R, Tobin WO, Young JR, Dasari S, Rech K, Ravindran A, Cleven AHG, Verdijk RM, van Noesel CJM, Balgobind BV, Bouma GJ, Saeed P, Bramer JAM, de Groen RAL, Vermaat JSP, van de Sande MAJ, Smit EF, Langerak AW, van Wezel T, Tonino SH, van den Bos C, van Laar JAM, Go RS, Goyal G, van Halteren AGS. BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis. Blood. 2023 Nov 2; 142 (18):1570-1575
    View PubMed
  30. Acosta-Medina AA, Abeykoon JP, Go RS, Goyal G, Ravindran A, Schram SM, Rech KL. BRAF testing modalities in histiocytic disorders: Comparative analysis and proposed testing algorithm. Am J Clin Pathol. 2023 Nov 2; 160 (5):483-489
    View PubMed
  31. Ravindran A, Dasari S, Ruan GJ, Artymiuk CJ, He R, Viswanatha DS, Abeykoon JP, Zanwar S, Young JR, Goyal G, Go RS, Rech KL, Mayo Clinic-The University of Alabama at Birmingham Histiocytosis Working Group. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells. Mod Pathol. 2023 Oct; 36 (10):100268 Epub 2023 July 04
    View PubMed
  32. Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO. Reply. Ophthalmology 2023 Sep; 130 (9):e33-e34 Epub 2023 June 10
    View PubMed
  33. Ravindran A, Rech KL. How I Diagnose Rosai-Dorfman Disease. Am J Clin Pathol. 2023 Jul 5; 160 (1):1-10
    View PubMed
  34. Chohan KL, Abeykoon JP, Young JR, Tobin WO, Koster MJ, Shah MV, Ryu JH, Vassallo R, Rech KL, Ravindran A, Goyal G, Go RS, Bennani NN. Sirolimus as frontline therapy for PTEN-mutated histiocytic sarcoma. Haematologica. 2023 Jun 1; 108 (6):1702-1706 Epub 2023 June 01
    View PubMed
  35. Banks SA, Sartori Valinotti JC, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Bennani NN, Shah MV, Rech KL, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology. Neurological Manifestations of Histiocytic Disorders. Curr Neurol Neurosci Rep. 2023 Jun; 23 (6):277-286 Epub 2023 May 20
    View PubMed
  36. Alizadeh M, Ravindran A, Chkheidze R, Goyal G, Hosseini M, Shobeiri P, Shafieioun A, Khalafi M, Shahidi R, Sotoudeh H, Singhal A. ALK-positive histiocytosis involving the cavernous sinus: A deceptive radiologic mimic of meningioma Radiol Case Rep. 2023.
  37. Sivasubramaniam P, Ravindran A. Anaplastic diffuse large B-cell lymphoma: a deceptive morphology. Blood Res. 2023 Mar 31; 58 (1):1 Epub 2023 Feb 27
    View PubMed
  38. Ravindran A, Pereira Palma LM, Fervenza FC, Sethi S. Overlap of C3 Glomerulopathy and Thrombotic Microangiopathy: A Case Series. Kidney Int Rep. 2023 Mar; 8 (3):619-627 Epub 2022 Dec 24
    View PubMed
  39. Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S, Morlote DM, King RL, Rummage C, Zanwar S, Acosta-Medina AM, Tobin WO, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status. JAMA Oncol. 2022 Dec 1; 8 (12):1816-1820
    View PubMed
  40. Ravindran A, Palma, Fervenza FC, Sethi S. Overlap of C3 glomerulopathy and thrombotic microangiopathy Kidney Int. Reports. 2022.
  41. Hazim AZ, Acosta-Medina AA, Young JR, Ruan GJ, Abeykoon JP, Ravindran A, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Shah MV, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findings. Br J Haematol 2022 Nov; 199 (3):454-457 Epub 2022 Aug 26
    View PubMed
  42. Ravindran A, Kurtin PJ, King RL, Yuan J, Feldman AL, Rech KL, McPhail ED, Parikh SA, Ding W, Shi M. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma. Hum Pathol. 2022 Jul; 125:2-10. Epub 2022 Apr 12.
    View PubMed
  43. Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes. Ophthalmology. 2023 Jan; 130 (1):77-86 Epub 2022 Aug 03
    View PubMed
  44. Alnoury M, Farag A, Ravindran A, Abozeed M. Pulmonary Mucormycosis: A Case Report Clinical Radiology and Imaging Journal. 2022; https://doi.org/10.23880/crij-16000208.
  45. Ravindran A, Said S, Shi M. Thinking Beyond the Marrow: Deceptive Presentation of a Rare Malignant Neoplasm. Mayo Clin Proc. 2022 Jul; 97 (7):1337-1338
    View PubMed
  46. Zanwar S, Abeykoon JP, Dasari S, Ravindran A, Young JR, Acosta-Medina AA, Rech KL, Schwartz J, Mangold A, Rosenthal A, Bennani NN, Shah MV, Morlote D, Goyal G, Go RS. Clinical and therapeutic implications of BRAF fusions in histiocytic disorders. Blood Cancer J 2022 Jun 28; 12 (6):97 Epub 2022 June 28
    View PubMed
  47. Hu M, Goyal G, Abeykoon JP, Acosta-Medina AA, Ruan GJ, Young JR, Ravindran A, Bennani NN, Shah MV, Vassallo R, Ryu JH, Davidge-Pitts CJ, Koster MJ, Tobin WO, Sartori-Valinotti JC, Rech KL, Go RS. Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis. Blood Cancer J 2022 Jun 3; 12 (6):89 Epub 2022 June 03
    View PubMed
  48. Zanwar S, Ravindran A, Abeykoon JP, Young JR, Kozelsky TF, Rech KL, Goyal G, Go RS. Prolonged remission with pembrolizumab and radiation therapy in a patient with multisystem Langerhans cell sarcoma. Haematologica. 2022 Sep 1; 107 (9):2276-2279 Epub 2022 Sept 01
    View PubMed
  49. Goyal G, Young JR, Abeykoon JP, Shah MV, Bennani NN, Sartori-Valinotti JC, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS. Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience. Oncologist. 2022 Mar 4; 27 (2):144-148
    View PubMed
  50. Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol. 2022 Mar 1; 97 (3):293-302 Epub 2022 Jan 03
    View PubMed
  51. Ravindran A, Macon WR, Rech KL. Histiocyte-rich pseudotumor - a post-chemotherapy radiologic dilemma. J Hematop. 2022 Mar; 15 (1):45-46 Epub 2022 Feb 04
    View PubMed
  52. Abeykoon JP, Ravindran A, Rech KL, Young JR, Oliver Tobin W, Shah MV, Nora Bennani N, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Mimics of Erdheim-Chester disease. Br J Haematol. 2022 Feb; 196 (4):984-994 Epub 2021 Nov 20
    View PubMed
  53. Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, Cox CW, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Shah MV, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 2021 Dec 1; 96 (12):1604-1610 Epub 2021 Oct 08
    View PubMed
  54. Abeykoon JP, Hampel PJ, King RL, Wood AJ, Larson MC, Nowakowski KE, Zanwar SS, Dasari S, Ruan GJ, Ravindran A, Wellik LE, Paludo J, Link BK, Cerhan JR, Ansell SM, Nowakowski GS, Thompson CA, Maurer MJ, Wenzl K, Novak AJ, Wu X, Habermann TM, Witzig TE. The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma. Haematologica. 2021 Aug 1; 106 (8):2261-2264 Epub 2021 Aug 01
    View PubMed
  55. Sturgis CD, Ravindran A, White D. Metastatic Thyroid Carcinoma in Bone: A Different Disease than Expected in an Elderly Male With Known Adenocarcinoma of Prostate. Mayo Clin Proc. 2021 Jun; 96 (6):1670-1671
    View PubMed
  56. Ravindran A, Greipp PT, Wongchaowart N, Smadbeck JB, Peterson JF, Ketterling RP, Kumar SK, Baughn LB. Dual Primary IGH Translocations in Multiple Myeloma: A Novel Finding. Clin Lymphoma Myeloma Leuk. 2021 Sep; 21 (9):e710-e713 Epub 2021 May 09
    View PubMed
  57. Goyal G, Abeykoon JP, Hu M, Young JR, Shah MV, Bennani NN, Call TG, Hook CC, Pardanani A, Inwards DJ, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis. Am J Hematol 2021 May 1; 96 (5):E146-E150 Epub 2021 Feb 19
    View PubMed
  58. Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2021 Apr 1; 45 (4):550-557
    View PubMed
  59. Ravindran A, Casal Moura M, Fervenza FC, Nasr SH, Alexander MP, Fidler ME, Herrera Hernandez LP, Zhang P, Grande JP, Cornell LD, Gross LA, Negron V, Jenson GE, Madden BJ, Charlesworth MC, Sethi S. In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes. J Am Soc Nephrol. 2021 Mar; 32 (3):695-706 Epub 2021 Jan 21
    View PubMed
  60. Abeykoon JP, Wu X, Nowakowski KE, Dasari S, Paludo J, Weroha SJ, Hu C, Hou X, Sarkaria JN, Mladek AC, Phillips JL, Feldman AL, Ravindran A, King RL, Boysen J, Stenson MJ, Carr RM, Manske MK, Molina JR, Kapoor P, Parikh SA, Kumar S, Robinson SI, Yu J, Boughey JC, Wang L, Goetz MP, Couch FJ, Patnaik MM, Witzig TE. Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair. Blood. 2021 Jan 28; 137 (4):513-523
    View PubMed
  61. Ravindran A, Goyal G, Go RS, Rech KL, Mayo Clinic Histiocytosis Working Group. Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2. Am J Surg Pathol. 2021 Jan; 45 (1):35-44
    View PubMed
  62. Hazim AZ, Ruan GJ, Ravindran A, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Young JR, Shah MV, Goyal G, Go RS. Efficacy of BRAF-Inhibitor Therapy in BRAF(V600E) -Mutated Adult Langerhans Cell Histiocytosis. Oncologist. 2020 Dec; 25 (12):1001-1004 Epub 2020 Oct 12
    View PubMed
  63. Abeykoon J, Wu X, Nowakowski KE, Dasari S, Paludo J, Weroha SJ, Hu C, Hou X, Sarkaria JN, Mladek AC, Phillips JL, Feldman A, Ravindran A, King RL, Boysen JC, Stenson M, Carr RM, Manske MK, Molina JR, Kapoor P, Parikh SA, Kumar SK, Robinson SI, Yu J, Boughey JC, Wang L, Goetz MP, Couch FJ, Patnaik MM, Witzig TE. CRM1 inhibitor anti-tumor activity is enhanced with salicylates by S-phase arrest and impaired DNA-damage repair. Blood. 2020 Nov 2 Epub 2020 Nov 02
    View PubMed
  64. Sethi S, Debiec H, Madden B, Vivarelli M, Charlesworth MC, Ravindran A, Gross L, Ulinski T, Buob D, Tran CL, Emma F, Diomedi-Camassei F, Fervenza FC, Ronco P. Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. Kidney Int. 2020 Nov; 98 (5):1253-1264 Epub 2020 June 11
    View PubMed
  65. Sethi S, Nast CC, D'Agati VD, Fervenza FC, Glassock RJ, Stokes MB, De Vriese AS, Appel GB, Chang A, Cosio F, Herrera Hernandez L, Markowitz GS, Kumar SK, Alexander MP, Amer H, Murray D, Nasr SH, Leung N, Pani A, Picken MM, Ravindran A, Roccatello D, Ronco P, Royal V, Smith KD, Wechalekar AD, Wetzels J, Zand L, Zhang P, Haas M. Standardized reporting of monoclonal immunoglobulin-associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group. Kidney Int. 2020 Aug; 98 (2):310-313 Epub 2020 Apr 23
    View PubMed
  66. Ravindran A, Lackore KA, Glasgow AE, Drake MT, Hobbs MA, Kourelis T, Kumar S, Kyle RA, Leung N, Muchtar E, Go RS. Monoclonal Gammopathy of Undetermined Significance: Indications for Prediagnostic Testing, Subsequent Diagnoses, and Follow-up Practice at Mayo Clinic. Mayo Clin Proc. 2020 May; 95 (5):944-954
    View PubMed
  67. Ravindran A, Madden B, Charlesworth MC, Sharma R, Sethi A, Debiec H, Cattran D, Fervenza FC, Smith RJ, Ronco P, Sethi S. Proteomic Analysis of Complement Proteins in Membranous Nephropathy. Kidney Int Rep. 2020 May; 5 (5):618-626 Epub 2020 Jan 30
    View PubMed
  68. Ravindran A, He R, Ketterling RP, Jawad MD, Chen D, Oliveira JL, Nguyen PL, Viswanatha DS, Reichard KK, Hoyer JD, Go RS, Shi M. The significance of genetic mutations and their prognostic impact on patients with incidental finding of isolated del(20q) in bone marrow without morphologic evidence of a myeloid neoplasm. Blood Cancer J. 2020 Jan 23; 10 (1):7
    View PubMed
  69. Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS, Mayo Clinic Histiocytosis Working Group. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica. 2020; 105 (2):348-357 Epub 2020 Jan 31
    View PubMed
  70. Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross L, Ravindran A, Buob D, Jadoul M, Fervenza FC, Ronco P. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 2020 Jan; 97 (1):163-174 Epub 2019 Oct 07
    View PubMed
  71. Goyal G, Ravindran A, Liu Y, He R, Shah MV, Bennani NN, Patnaik MM, Rech KL, Go RS, Mayo Clinic Histiocytosis Working Group. Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms. Haematologica 2020; 105 (2):e84-e86 Epub 2020 Jan 31
    View PubMed
  72. Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS, Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc. 2019 Oct; 94 (10):2054-2071 Epub 2019 Aug 28
    View PubMed
  73. Goyal G, Liu Y, Ravindran A, Al-Kali A, Go RS, Patnaik MM, Rech KL, Mayo Clinic Histiocytosis Working Group. Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin. Br J Haematol 2019 Oct; 187 (2):e51-e54 Epub 2019 Sept 02
    View PubMed
  74. Berti A, Cornec-Le Gall E, Cornec D, Casal Moura M, Matteson EL, Crowson CS, Ravindran A, Sethi S, Fervenza FC, Specks U. Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort. Nephrol Dial Transplant. 2019 Sep 1; 34 (9):1508-1517
    View PubMed
  75. Hsieh RW, Ravindran A, Hook CC, Begna KH, Ashrani AA, Pruthi RK, Marshall AL, Hogan W, Litzow M, Hoyer J, Oliveira JL, Vishnu P, Call TG, Al-Kali A, Patnaik M, Gangat N, Pardanani A, Tefferi A, Go RS. Etiologies of Extreme Thrombocytosis: A Contemporary Series. Mayo Clin Proc. 2019 Aug; 94 (8):1542-1550
    View PubMed
  76. Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, Hummel AM, Specks U, Fervenza FC, Ronco P. Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. J Am Soc Nephrol. 2019 Jun; 30 (6):1123-1136 Epub 2019 May 06
    View PubMed
  77. Ravindran A, Rech KL. Mayo Clinic Pathways Case Study Langerhans cell sarcoma.. 2019.
  78. Ravindran A, Cortese C, Larsen CP, Wadei HM, Gandhi MJ, Cosio FG, Sethi S. Karyomegalic interstitial nephritis in a renal allograft. Am J Transplant. 2019 Jan; 19 (1):285-290 Epub 2018 Aug 20
    View PubMed
  79. Ravindran A, Fervenza FC, Smith RJH, Sethi S. The Authors Reply: Response to Conservative treatment for C3 glomerulopathy and monoclonal Ig Kidney Int.. 2018.
  80. Ravindran A, Kashtan CE, Sethi S. BK nephropathy with glomerular involvement. Kidney Int. 2018 Aug; 94 (2):432
    View PubMed
  81. Ravindran A, Fervenza FC, Smith RJH, De Vriese AS, Sethi S. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic. Mayo Clin Proc. 2018 Aug; 93 (8):991-1008
    View PubMed
  82. Ravindran A, Goyal G, Failing JJ, Go RS, Rech KL. Florid dermatopathic lymphadenopathy-A morphological mimic of Langerhans cell histiocytosis. Clin Case Rep. 2018 Aug; 6 (8):1637-1638 Epub 2018 June 22
    View PubMed
  83. Ravindran A, Fervenza FC, Smith RJH, Sethi S. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int. 2018 Jul; 94 (1):178-186 Epub 2018 May 03
    View PubMed
  84. Ravindran A, Go RS, Reichard KK, Marshall AL. Evaluation of thrombocytopenia in the hematology clinic: a case series from a large tertiary care center. Blood Res. 2018 Jun; 53 (2):166-167 Epub 2018 June 25
    View PubMed
  85. Ravindran A, Smyrk TC. Mayo Clinic Pathways Case Study Ciliated Foregut Cyst of Pancreas. 2018.
  86. Ravindran A, Smyrk TC. Mayo Clinic Pathways Case Study Ciliated Foregut Cyst of Pancreas. 2018.
  87. Jawad MD, Go RS, Witzig TE, Mikhael JR, Ravindran A, Murray DL, Murrray DL. Pseudo-monoclonal gammopathy: a report of four cases. Haematologica 2017 Nov; 102 (11):e466-e469 Epub 2017 Aug 03
    View PubMed
  88. Ravindran A, Fervenza FC, Smith RJH, Sethi S. C3 glomerulonephritis with a severe crescentic phenotype. Pediatr Nephrol. 2017 Sep; 32 (9):1625-1633 Epub 2017 June 07
    View PubMed
  89. Hansen BR, Bottner WA, Ravindran A, DeJesus R, Go RS. A follow-up on desiderosmia (olfactory craving) A novel symptom associated with iron deficiency anemia. Am J Hematol. 2017.
  90. Ravindran A, Sankaran J, Jacob EK, Kreuter JD, Hook CC, Gertz MA, Call TG, Pruthi RK, Litzow MR, Wolanskyj AP, Hogan WJ, Ashrani AA, Begna KH, Marshall AL, Kyle RA, Kay NE, Go RS. High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia. Am J Hematol 2017 Aug; 92 (8):E164-E166 Epub 2017 June 01
    View PubMed
  91. Ravindran A, Go RS, Fervenza FC, Sethi S. The Authors Reply Response to Complement-dependent, monoclonal gammopathy–associated thrombotic microangiopathy. Kidney Int.. 2017.
  92. Hansen BR, Bottner, Ravindran A. Desiderosmia (olfactory craving) A novel symptom associated with iron deficiency anemia. Am J Hematol : E93-E4. PMID: 28240803. 2017.
  93. Ravindran A, Go RS, Fervenza FC, Sethi S. Thrombotic microangiopathy associated with monoclonal gammopathy. Kidney Int. 2017 Mar; 91 (3):691-698 Epub 2016 Dec 18
    View PubMed
  94. Ravindran A, Gonsalves WI, Hashmi SK, Kapoor P, Marshall AL, Siddiqui MA, Go RS. Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely? Leuk Lymphoma 2017 Jan; 58 (1):251-252 Epub 2016 June 09
    View PubMed
  95. Ravindran A, Bartley AC, Holton SJ, Gonsalves WI, Kapoor P, Siddiqui MA, Hashmi SK, Marshall AL, Ashrani AA, Dispenzieri A, Kyle RA, Rajkumar SV, Go RS. Prevalence, incidence and survival of smoldering multiple myeloma in the United States. Blood Cancer J 2016 Oct 21; 6 (10):e486
    View PubMed
  96. Ravindran A, Grogg KL, Domaas DA, Go RS. Polyclonal Localized Light Chain Amyloidosis-A Distinct Entity? Clin Lymphoma Myeloma Leuk. 2016 Oct; 16 (10):588-592 Epub 2016 Aug 10
    View PubMed
PST-20346378